Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey A Cohen

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI TrialHanny Al-Samkari, Joseph J Shatzel, Sandhya R Panch, et al.
Cancer|August 26, 2017
Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family RegistryJonathan M Kocarnik, Xinwei Hua, Sheetal Hardikar, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2020
Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)Julia D Labadie, Xinwei Hua, Tabitha A Harrison, et al.
Cancer|February 22, 2024
SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal CancerVirginia Sun, Katherine A Guthrie, Tracy E Crane, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2023
Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent AdenomasMing Yu, Kelly T Carter, Kelsey K Baker, et al.
Gastroenterology|June 16, 2016
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesStacey A Cohen, Emily H Turner, Mallory B Beightol, et al.
The Oncologist|September 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal AdenocarcinomasAdam C Diehl, Lindsay M Hannan, David B Zhen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2024
Alcohol Consumption and Smoking History at the Time of Diagnosis and the Risk of Colorectal Cancer Recurrence and Mortality: Results from the ColoCare StudyNicole C Loroña, Caroline Himbert, Jennifer Ose, et al.
Contemporary Clinical Trials|June 28, 2023
Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility studyStacey A Cohen, Susan Veleber, Jonathan Siman, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI TrialHanny Al-Samkari, Joseph J Shatzel, Sandhya R Panch, et al.
Cancer|August 26, 2017
Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family RegistryJonathan M Kocarnik, Xinwei Hua, Sheetal Hardikar, et al.
JCO Oncology Practice|December 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisAmy H Huang, Gin Yi Lee, Chuan Angel Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2020
Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)Julia D Labadie, Xinwei Hua, Tabitha A Harrison, et al.
Cancer|February 22, 2024
SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal CancerVirginia Sun, Katherine A Guthrie, Tracy E Crane, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2023
Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent AdenomasMing Yu, Kelly T Carter, Kelsey K Baker, et al.
Gastroenterology|June 16, 2016
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesStacey A Cohen, Emily H Turner, Mallory B Beightol, et al.
The Oncologist|September 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal AdenocarcinomasAdam C Diehl, Lindsay M Hannan, David B Zhen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2024
Alcohol Consumption and Smoking History at the Time of Diagnosis and the Risk of Colorectal Cancer Recurrence and Mortality: Results from the ColoCare StudyNicole C Loroña, Caroline Himbert, Jennifer Ose, et al.
Contemporary Clinical Trials|June 28, 2023
Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility studyStacey A Cohen, Susan Veleber, Jonathan Siman, et al.
Pageof 6